FIELD: biotechnology, medicine.
SUBSTANCE: invention relates to a method for preparing components of biological glue from plasma blood pool that give in together highly qualitative virus-safety product with the high yield. Product comprising triply inactivated viruses and no containing fibrinogen, fibronectin and factor XIII is prepared firstly by treatment of its concentrate with virucidal solution of solvent/detergent and then by nanofiltration of viruses and, finally, by thermal treatment. Method of invention doesn't effect on the yield highly qualitative product. Invention provides the improvement of the known patented method with elevating yield of active thrombin by about two-fold.
EFFECT: improved producing method, high yield of product.
16 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
| METHOD OF LARGE-SCALE PRODUCTION OF THROMBIN-CONTAINING COMPOSITION OF THERAPEUTIC PURITY DEGREE AND STABLE IN STORAGE | 1995 |
|
RU2144081C1 |
| METHOD OF PRODUCING THROMBIN CONCENTRATE | 2014 |
|
RU2583931C2 |
| METHOD OF PREPARING BIOLOGICAL ADHESIVE MADE OF CONCENTRATED COAGULATING FACTORS BY SALTING OUT | 1994 |
|
RU2130946C1 |
| METHOD FOR CLEANING FIBRINOGEN, FIBRINOGEN PRODUCT AND MEANS FOR CLEANING OR PRODUCING FIBRINOGEN PRODUCT | 2013 |
|
RU2663792C2 |
| METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
| METHOD OF FIBRIN CLOT ADMINISTRATION (ITS VARIANTS) AND AGENT KIT FOR ITS ADMINISTRATION (VARIANTS) | 1991 |
|
RU2104701C1 |
| METHOD FOR PRODUCING AUTOLOGOUS FIBRIN WITH CONTROLLED FIBRINOGEN CONTENT WITHOUT USING EXOGENOUS THROMBIN | 2020 |
|
RU2758260C1 |
| PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
| METHOD OF CLEANING THROMBIN SOLUTION FROM INFECTIOUS PARTICLES | 2007 |
|
RU2468032C2 |
